Stefanos Almpanis

Job title

Consultant Urological Surgeon

Contact details

Tel: 02 0888 72431

Email: Northmid.urology@nhs.net 

Related services

Urology

Location

North Middlesex University Hospital

Biography

I am an experienced endourologist and general urologist, with 30 years in urological practice. I had the opportunity to complete an advanced urological training in EAU accredited centres and I was a senior lecturer in urology in the University Of Athens Medical School.

I am a strong supporter of patient-doctor partnership, patient safety and patient satisfaction.

I lead the haematuria and the stones clinical practice groups of my hospital, representing it in the region as part of NCL (North Central London) working group, CPG (Clinical Practice Group) and GIRFT (Get It Right First Time) program for urology.

I developed and lead the SSIP (Stone Service Improvement Project) in my department since 2012, which led to a substantive and holistic stone service provided in a multidisciplinary model.

Languages

Greek and English

GMC number

6042417

  1. ‘The IDENTIFY study: the investigation and detection of urological neoplasia in patients referred with suspected urinary tract cancer - a multicentre observational study’. (Stephanos Almpanis: Collaborator representing NMH). Observational Study BJU Int. 2021 Oct;128(4) 
  2. Genitourinary tuberculosis presenting as treatment resistant dysuria in a young patient: a case report. Woodward L, Sahin A, Almpanis S. J Surg Case Rep. 2024 Dec 26;2025 
  3. ‘Bilateral synchronous intravaginal testicular torsion presenting with unilateral testicular pain’. M Taheem, M Ziada, V Arumugam, Z Lamond, S Almpanis. J Surg Case Rep. 2022 Jan; 2022 
  4. ‘Stent Cards: A simple solution for forgotten stents?’ BMJ Open Qual. 2019; 8(2): e000612. Published online 2019 May 29. doi: 10.1136/bmjoq-2018-000612 PMCID: PMC6542425 PMID: 31206067, Masood M, Almpanis S 
  5. Anuria and acute kidney injury: an uncommon case of bilateral synchronous ureteric calculi. Vadhwana B, Carey G, Almpanis S, Bell DJ. Am J Emerg Med. 2016 Nov;34(11) 
  6. Benign cystic mesothelioma:a rare cause for scrotal swelling. Aber A, Tahir A, Arumuham V, Smith G, Almpanis S. Case Report Med. 2012 
  7. An interventional urology list – a novel concept for UK urological services. Masood J, Ismail M, El-Husseiny T, Moraitis K, Albanis S, Papatsoris A, Buchholz N.Ann R Coll Surg Engl. Jan;93(1):27-30, 2011 
  8. Laparoscopic urinary stone surgery: an updated evidence-based review. Skolarikos A, Papatsoris A, Albanis S, Assimos D. Urol Res, Oct;38(5):337-44, 2010 
  9. Management of ureteric strictures with the Memokath 051® stent. Almpanis S, Liakouras Ch, Papatsoris A, Masood J, Deliveliotis Ch, Buchholz N. Hellenic Urology, June 2010. 
  10. Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: results from a randomised phase 3 study of the south European uroncological group. Da Silva F, Bono A, Whelan P, Albanis S et al. Eur Urol, Jun;55:1269-77, 2009 
  11. Inversion, hydration and diuresis during extracorporeal shock wave  lithotripsy: does it improve stone free rate for lower pole stone clearance? Albanis S, Hammad A, Papatsoris A, Masood J, Staios D, Buchholz N. Urol Int, Sep;83(2):211-216, 2009 
  12. Material fatigue testing of a new intraureteral wire stent (Zebrastent). Staios D, Patel M, Papatsoris A, Albanis S, Birch M, Buchholz N. J Endourol, Jun;22(6):1389-93, 2008 
  13. Laparoscopic transposition of lower-pole crossing vessels in the management of pelvi-ureteric junction obstruction. Zaman F, Masood J, Papatsoris A, Albanis S, Junaid I, Buchholz N. BJU Int, Jun;101(12):1490-92, 2008 
  14. The Nutcracker phenomenon – case report and review of literature. Hersey N, Masood J, Papatsoris A, Staios D, Buchholz N, Albanis S. Curr Urol, 1: 110-112, 2007 
  15. Repositioning and removal of an intra-renal migrated ureteric Memokath® stent. Siddique K, Zammit P, Bafaloukas N, Albanis S, Buchholz N. Urol Int, 77(4):297-300, 2006 
  16. The (soon forgotten) art of open stone surgery: to train or not to train? Buchholz N, Hitchings A, Albanis S. Ann R Coll Surg Engl, Mar;88(2):214-17, 2006 
  17. DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladder. Deliveliotis Ch, Georgoulakis J, Skolarikos A, Trakas N, Varkarakis J, Albanis S, Protogerou V, Bamias A. Urol Res, Feb;33(1):39-43, 2005  
  18. Unreliable residual volume measurement after increased water load diuresis. Alivizatos G, Skolarikos A, Albanis S, Ferakis N, Mitropoulos D. Int J Urol, Dec;11(12):1078-81, 2004 
  19. Retrograde acucise endopyelotomy: is it worth its cost? Sofras F, Livadas K, Alivizatos G, Deliveliotis Ch, Albanis S, Melekos M, Christoforidis K. J Endourol, Jun;18(5):466-68, 2004 
  20. Comparison of success rates and financial cost of extracorporeal shock wave lithotripsy in situ and after manipulation for proximal ureteral stones. Varkarakis J, Protogerou V, Sofras F, Albanis S, Deliveliotis Ch. Urol Res, Aug;31(4):286-90, 2003 
  21. Management and follow-up of impacted ureteral stones. Deliveliotis Ch, Chrisofos M, Albanis S, Serafetinidis E, Varkarakis J, Protogerou V. Urol Int, 70(4):269-72, 2003 
  22. Shockwave lithotripsy for urinary stones in patients with urinary diversion after radical cystectomy. Deliveliotis C, Varkarakis J, Argiropoulos V, Protogerou V, Skolarikos A, Albanis S, Constantine D. J Endourol, Dec;16(10):712-20, 2002 
  23. Solitary neurofibroma of the spermatic cord. Deliveliotis C, Albanis S, Skolarikos A, Varkarakis J, Protogerou V, Tamvakis N, Alargof E. Int Urol Nephrol, 34(3):373-75, 2002 
  24. Synchronous diagnosis of prostatic adenocarcinoma and sarcoidosis. Deliveliotis C, Albanis S, Protogerou V, Varkarakis J, Alargof E, Chrisofos M. Int Urol Nephrol, 34(3):361-63, 2002 
  25. Extracorporeal shock wave lithotripsy produces a lower stone-free rate in patients with stones and renal cysts. Deliveliotis C, Argiropoulos V, Varkarakis J, Albanis S, Skolarikos A. Int J Urol, Jan;9(1):11-14, 2002 
  26. Biopsies of the transitional zone of the prostate. Should it be done on a routine basis, when and why? Deliveliotis C, Varkarakis J, Albanis S, Argyropoulos V, Skolarikos A. Urol Int, 68(2):113-17, 2002 
  27. Hydatid cyst of the kidney and the retroperitoneum: two interesting cases. Karayannis A, Giannakopoulos S, Louras G, Varkarakis I, Albanis S. Hellenic Urology, Oct-Dec;10(2):373-78, 1998 

Monographs: DNA Ploidy as a Prognostic Factor for Long Term Survival of Patients Suffering from Bladder Cancer and who were Treated by Curative Radical Cystoprostatectomy 

Albanis S. PhD Thesis. University of Athens Library, 2004 

Book chapters 

  1. Urological Trauma. Albanis S: In: Deliveliotis Ch (eds). Urology, 2009 
  2. Haematuria. Harper M, Albanis S, Virdi J: In: Shergill I, Arya M, Patel H, Gill I (eds). Urological Emergencies in Hospital Medicine, pp. 11-16, 2007 
  3. Open stone surgery – a soon forgotten art. Buchholz N, Albanis S, Andrews HO, Mburugu P, Ahmad MW: In: Gohel MD, Au DWT (eds) Kidney Stones: Inside & Out. The Hong Kong Polytechnic University, Hong Kong, China, pp. 273, 2004 

Letters to the Editor 

  1. Re: Billis et al.: Does the type of prostatic atrophy influence the association of extent of atrophy in needle biopsies and serum prostate-specific antigen levels? (Urology 2009;74:1111-1115). 

Papatsoris A, Albanis S, Deliveliotis C. Urology. 2010 May;75(5):1239;  

  1. Transurethral resection of the prostate. Georgakopoulos D, Albanis S, Nargund V. BJU Int, Feb;99(2):464-65, 2007 

Invited Contributions 

‘Urology Training in the UK’  

Analysis of the urological training in the UK and comparison with the former training system 

HUA Quarterly Bulletin. 2007 

Reviewer for the Journal of Endourology 

Reviewer for BMJ 

Abstracts: 33 

Presentations, Posters & Videos: >65 

 

Bladder Cancer, haematuria, urolithiasis, emergency urology

RESECT Study is a global multicentre observational audit with randomised feedback, assessing bladder cancer resection and chemotherapy single bladder installation practices aiming to improve homogeneity and quality of bladder cancer initial management.  

1. The study of oestrogen receptors ER (a) and ER (b), in relation to androgen receptors, as a prognostic factor for biochemical recurrence and disease progression for locally advanced prostate cancer. 

2. Myopondin as a tumour prognostic factor for recurrence and invasion in non-invasive transitional cell carcinoma of the bladder. 

3. Intermittent CAB for prostate cancer patients. Study on QoL, compliance, PSA, disease-specific survival. Multicentre prospective randomised study, organised by South European Uro-oncological Group (SEUG). Principal Investigator: Professor Da Silva, Portugal.